In the second part of this roundtable discussion, participants highlight best practices for reaching underrepresented populations and increasing their awareness of clinical trials.
Related Posts
Peter Ronco Offers Tips to Small Biopharma Companies on Properly Scaling Clinical Programs
ACT: What advice do you have for small biopharma companies looking to scale their clinical programs without overextending resources? Ronco:…
Real-World Data Show 99% Efficacy for Apretude in HIV Prevention with High Adherence, Reduced Stigma
Credit: jarun011 | stock.adobe.com Real-world data demonstrated that Apretude (cabotegravir long-acting [CAB-LA]; ViiV Healthcare) for HIV pre-exposure prophylaxis (PrEP) produced…
How In-Home and Community Strategies Boost Recruitment and Diversity
In a recent video interview Applied Clinical Trials, Caroline Potts, general manager of sites and patient services, Medical Research Network…